True Binding
Advertisement
TrueBinding Inc. is a clinical-stage biotherapeutic company focused on developing novel monoclonal antibody therapeutics for neurodegenerative and metabolic diseases, oncology, and other areas with significant unmet medical needs. The company is dedicated to revolutionizing patient care through its innovative pipeline, aimed at providing targeted treatments that enhance patient outcomes and therapeutic options.
With a commitment to accelerating biopharmaceutical innovation, TrueBinding offers contract development and manufacturing services to expedite the development of high-quality monoclonal antibodies. The company's Expanded Access Program provides compassionate access to investigational medications for patients with Alzheimer's disease, while ongoing clinical trials explore potential treatments for other conditions, including autism spectrum disorder and Parkinson's disease.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement
